Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

1.4K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clearance of Senescent Cells by BCL<sub>XL</sub>-PROTAC: A Novel Approach to Treat COPD?

Aging cell·2026
Same author

Single-cell microfluidic quantification of miRNA-21 and miRNA-34a reveals miRNA interactions in small airway epithelial cells and fibroblasts from patients with COPD.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Catalogue of LPS-induced transcriptional changes across vertebrates identifies syntenically conserved human long non-coding RNAs that regulate the innate immune response.

Frontiers in immunology·2026
Same author

Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice.

Frontiers in medicine·2025
Same author

Chronic Obstructive Pulmonary Disease Airway Epithelial Cell-derived Extracellular Vesicles Spread Cellular Senescence via MicroRNA-34a.

American journal of respiratory cell and molecular biology·2025
Same author

Identification of an emphysema-specific ATII cell: a step towards understanding impaired lung regeneration in COPD?

The European respiratory journal·2024

相关实验视频

Updated: Jun 10, 2025

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure
08:54

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

9.1K

呼吸道疾病中的巨细胞功能障碍

Shyreen Hassibi1, Louise E Donnelly2

  • 1Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.

Results and problems in cell differentiation
|October 15, 2024
PubMed
概括

肺巨对肺部健康至关重要,但在COPD和喘等肺部疾病中变得功能障碍. 了解这些变化可能会导致针对衰弱性呼吸道疾病的新向疗法.

科学领域:

  • 肺免疫学和细胞生物学
  • 呼吸系统医学和疾病病理学

背景情况:

  • 肺巨细胞是肺中的关键免疫细胞,通过清除病原体和亡细胞来维持恒常状态是必不可少的.
  • 肺部疾病,包括COPD,喘,囊性纤维化和IPF,影响全球数百万人,并以异常巨细胞功能为特征.
  • 肺部疾病中的功能障碍巨细胞表现出减少的细胞体和一种亲炎性表型,损害了它们解决炎症的能力.

研究的目的:

  • 审查了解肺巨的起源,表型和功能方面的最新进展.
  • 探索巨细胞在肺部恒温和疾病发病过程中的作用.
  • 要突出代谢和线粒体变化,有助于肺部疾病的巨细胞功能障碍.

主要方法:

  • 谱系追踪研究研究.
  • 单细胞RNA测序的一个细胞.
  • 对肺部疾病和巨细胞生物学现有文献的审查.

主要成果:

  • 肺巨细胞在肺恒温,病原体清除和炎症解消中发挥着至关重要的作用.
  • 肺部疾病与巨细胞表型的显著变化有关,包括细胞能力降低和炎症增加.
  • 代谢和线粒体失调是共同的特征,有助于在各种肺部疾病中促进炎症性巨细胞表型.

结论:

关键词:
膜细胞巨细胞.喘 喘 是一种慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.囊性纤维化症是什么在IPF中,IPF是IPF.

更多相关视频

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
09:09

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

23.6K
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.4K

相关实验视频

Last Updated: Jun 10, 2025

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure
08:54

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

9.1K
Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages
09:09

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

23.6K
Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

2.4K
  • 肺部巨细胞是肺部健康和疾病的核心.
  • 由疾病特异性环境因素和代谢变化驱动的异常巨细胞功能,有助于肺部疾病的进展.
  • 针对驱动巨细胞功能障碍的机制,有望为慢性肺部疾病开发新型疗法.